Sangamo Therapeutics Chapter 11 Report Shows $23.2M Cash, $107.3M Liabilities
Sangamo Therapeutics’ monthly operating report shows month-end cash of $23,225,696 and total liabilities of $107,262,249.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.